Advertisement
UK markets close in 6 hours

  • FTSE 100

    8,107.14
    +28.28 (+0.35%)
     

  • FTSE 250

    19,828.20
    +226.22 (+1.15%)
     

  • AIM

    755.98
    +2.86 (+0.38%)
     

  • GBP/EUR

    1.1655
    -0.0001 (-0.01%)
     

  • GBP/USD

    1.2513
    +0.0003 (+0.02%)
     

  • Bitcoin GBP

    51,548.03
    +358.75 (+0.70%)
     

  • CMC Crypto 200

    1,390.62
    -5.92 (-0.42%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CRUDE OIL

    83.75
    +0.18 (+0.22%)
     

  • GOLD FUTURES

    2,363.10
    +20.60 (+0.88%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,041.62
    +124.34 (+0.69%)
     

  • CAC 40

    8,029.93
    +13.28 (+0.17%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Healthcare platform Agilon targets valuation of up to $9 billion in U.S. IPO

Reuters
Updated ·1-min read

(Reuters) - Agilon Health is aiming for a valuation of up to $9 billion in its initial public offering (IPO), the healthcare platform said on Wednesday, joining a clutch of companies looking to cash in on the record run in U.S. capital markets.

The company said it planned to raise more than $1 billion in its IPO by selling 46.6 million shares at a price range of $20 and $23 per share.

Founded in 2016, Agilon health provides a care platform for primary care physicians.

The company will list on the New York Stock Exchange under the symbol "AGL," it said in a filing.

JP Morgan, Goldman Sachs and BofA are among the underwriters for the offering.

(Reporting by Niket Nishant and Mrinalika Roy in Bengaluru; Editing by Aditya Soni)